Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX10 + chemotherapy
Cervical Cancer
phase 2

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

HLX10+Chemotherapy
Extensive Stage Small Cell Lung Cancer
Phase 3
A Randomized, Double-blind, Placebo?Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
HLX10+chemotherapy
Squamous Non Small Cell Lung Cancer
Phase 3
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
HLX10+Chemotherapy
Esophageal Squamous Cell Carcinoma
Phase 3
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
HLX10+Chemotherapy
Non-Small-Cell Lung Cancer
Phase 3
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
hg320挂赚钱宝网络卡 海南环岛赛体彩规律表 佳永配资平台介绍 11选5万能6码40注 股指期货配资最大平台 辽宁11选五开奖结果查询 北京快乐彩8 福建22选5中奖规则及奖金 万达股票 黑龙江11远五 20040810期快乐扑克开奖号 必出二码 11选5前三组出号规律 大类配资 宁夏11远五开奖查询 江西时时彩历史 上证指数最高点